NTI

15.5%

4.9¢ neurotech international limited

Well said mate in keeping with the media thread. Merchant...

First 31 Last

Share
Profile

Follow
Bigmuzza16

134 Posts.

9

21/09/22

20:43

Post #: 63824431
Share

Originally posted by glory: ↑

All4Info,

I think you will analysis yourself out of this stock if not careful.

All exploration and growth companies always need capital. I was and still am a sizeable shareholder of Lin- a rare earth company unrecognised by the market for years. I was able to buy for almost 9 months, while many remained negative and never bought. Once the trigger was pulled- being a dispute settlement, which to me was a no brainer, the price started to appreciate substantially. Then the focus was on their need for money, instead on the intrinsic value of the asset, people worried about the next raising-- they missed the boat again.
Both subsequent raising were at almost a 30% and 40 % premium to the price -- why?, the stock was not reflecting the true value which this single investor saw in the company. -- First raising at 10c when stock was 7 to 8c, after flying from 3c. The Next was at 20c when the stock was 13c. It now 28c.

No doubt NTI needs money , but all those focused on this, rather than trying to get an understanding of its intrinsic or potential upside, I believe will miss out on another multi bagger.

I believe with the current results on their ASD trials - a syndrome that effects so so many people, in fact almost everyone either knows someone who is directly or indirectly affected by Autism, -- we are potentially sitting on a multi multi billion dollar company over the next 2 to 3 years.

Therefore, we need only convince 1 decent investor of this, and many many may miss the boat, but not me, I'm still buying.

Why worry about a cent or two if you believe in its potential and are a long term investor. I understand for traders entry points are important, each to their own.

Not guaranteed but I am a punter and understand the risk, -- its not for everyone.

GLTAH

Expand

Well said mate

in keeping with the media thread. Merchant Financial spoke of NTI in their monthly update to fund members.

NTI Price at posting: 9.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 20 more messages in this thread...

First 31 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 4.9¢		Change -0.009(15.5%)		Mkt cap ! $50.69M

Open	High	Low	Value	Volume
5.4¢	5.4¢	4.8¢	$180.7K	3.515M

Buyers (Bids)

No.	Vol.	Price($)
2	1625764	4.9¢

Sellers (Offers)

Price($)	Vol.	No.
5.2¢	98041	1

View Market Depth

No.	Vol.	Price($)
2	1625764	0.049
3	240000	0.048
2	101600	0.047
1	110000	0.046
4	205149	0.045

Price($)	Vol.	No.
0.052	98041	1
0.053	330000	3
0.054	146800	2
0.057	80000	1
0.058	60000	2

Last trade - 16.10pm 04/10/2024 (20 minute delay)

NTI (ASX) Chart

Well said mate in keeping with the media thread. Merchant...

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Well said mate in keeping with the media thread. Merchant...

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News